Helvetica Chimica Acta – Vol. 89 (2006)
115
2,3-Dihydro-4,7-dimethyl-5-(2-nitrophenyl)-1H-inden-2-yl Acetate (6b). A mixture of 3c (0.41 g, 1.24
mmol), 2-nitrobenzeneboronic acid (0.33 g, 1.98 mmol), NaHCO3 (0.42 g, 5 mmol), and [Pd(PPh3)2Cl2]
(20 mg, 2 mol-%) was placed in a two-neck, round-bottom flask purged with N2. Then, a 1:1 mixture
of 1,2-dimethoxyethane (DME) and H2O (8 ml in total) was added through a rubber septum, and the
mixture was heated at 808 for 18 h. Then, the org. solvents were evaporated, and the aq. residue was
taken up in CH2Cl2. The org. soln. was washed with H2O, dried (Na2SO4), evaporated, and purified by
CC (SiO2) to afford 6b. Yield: 0.32 g (79.2%). IR: 2943, 2920, 1734, 1609, 1571, 1527, 1469, 1437, 1350,
1
1244, 1194, 1021, 977, 873, 854, 786, 758, 708. H-NMR: 1.95 (s, 3 H); 2.04 (d, J=6.9, 3 H); 2.20 (s, 3
H); 2.95–3.02 (m, 2 H); 3.24–3.35 (m, 2 H); 5.54–5.58 (m, 1 H); 6.78 (s, 1 H); 7.27–7.32 (m, 1 H);
13
7.43–7.49 (m, 1 H); 7.56–7.61 (m, 1 H); 7.90–7.31 (m, 1 H). C-NMR3): 16.18/16.19 (q); 18.53/21.12
(q); 38.50/38.61 (t); 38.84/38.98 (t); 74.48/74.62 (d); 123.69/123.72 (d); 127.88 (d); 127.99 (d); 128.70
(s); 130.77 (s); 132.15/132.17 (d); 132.29/135.93 (s); 136.41/138.89 (s); 139.39 (s); 139.42 (s); 149.25 (s);
170.83/170.99 (s). EI-MS: 325 (M+), 295, 282, 265, 248, 234, 218, 203, 178, 165, 152, 146, 115, 101, 91,
77. HR-MS: 325.1316 (M+, C19H19NO4þ ; calc. 325.1315).
1,2,3,5-Tetrahydro-4,10-dimethylcyclopenta[b]carbazol-2-yl Acetate (5d). A mixture of 6b (0.32 g,
0.98 mmol) and P(OEt)3 (5 ml) was heated at 1508 under N2 for 5 h. Excess (OEt)3P and (OEt)3P=O
were distilled off at reduced pressure to leave a brown residue, which was purified by CC (SiO2) to afford
5d. Yield: 0.21 g (72.8%). IR: 3280, 2740, 1707, 1610, 1517, 1368, 1304, 1263, 1194, 1014, 976, 839, 773, 730.
1H-NMR: 1.97 (s, 3 H); 2.33 (s, 3 H); 2.66 (s, 3 H) 3.01–3.11 (m, 2 H); 3.29–3.38 (m, 2 H); 5.51–5.57 (m,
1 H); 7.11–7.16 (m, 1 H); 7.26–7.37 (m, 2 H); 7.88 (br., 1 H); 8.06–8.09 (m, 1 H). 13C-NMR: 13.51 (q);
16.93 (q); 21.38 (q); 38.07 (t); 38.57 (t); 75.44 (d); 110.37 (d); 112.48 (s); 119.15 (d); 120.98 (s); 122.27 (d);
124.51 (d); 125.85 (s); 130.52 (s); 136.73 (s); 138.69 (s); 139.66 (s); 171.33 (s). EI-MS: 293 (15, M+), 234
(24), 233 (100), 218 (48), 117 (6). HR-MS: 293.1421 (M+, C19H19NO2þ ; calc. 293.1417).
cis- (8c) and trans-1,2,3,5-Tetrahydro-4,10-dimethylcyclopenta[b]carbazole-1,2-diol (8d). To a stirred
mixture of 5d (0.30 g, 1 mmol) and H2O (0.15 g, 8.0 mmol) in THF (5 ml), a soln. of DDQ1) (0.93 g, 4.1
mmol) in THF (10 ml) was added dropwise at 08 over 10 min. After 8 h, the mixture was treated with 50%
aq. K2CO3 soln. (10 ml) and stirred for another 1 h. The solvent was evaporated, the residue was
extracted repeatedly with CH2Cl2/MeOH 10 :1, and the combined extracts were washed with sat. aq.
K2CO3 soln., dried (Na2SO4), and evaporated. The residue (0.26 g) was dissolved in anh. THF (10 ml),
and then dropwise added to a stirred suspension of LiAlH4 (0.26 g, 6.8 mmol) in THF (5 ml). After 10
h, excess hydride was carefully destroyed with H2O. The resulting mixture was filtered, and washed
with CH2Cl2. The combined org. soln. was washed with sat. aq. K2CO3 soln., dried (Na2SO4), and evapo-
rated. The residue was purified by CC (SiO2) to afford 8c (0.06 g, 21.9%) and 8d (0.13 g, 47.6 %).
Data of 8c (cis). IR: 3419, 2923, 2085, 1645, 1519, 1456, 1338, 1297, 1235, 1118, 1085, 1002, 740. 1H-
NMR (CD3OD): 2.40 (s, 3 H); 2.82 (s, 3 H); 2.96 (dd, J=15, 8.7, 1 H); 3.19 (dd, J=15, 7.2, 1 H); 4.31
(ddd, J=8.7, 7.2, 5.4, 1 H); 5.09 (d, J=5.4, 1 H); 7.09–7.14 (m, 1 H); 7.27–7.33 (m, 1 H); 7.43–7.46
(m, 1 H); 8.07–8.10 (m, 1 H). 13C-NMR (CD3OD): 13.53 (q); 16.63 (q); 37.37 (t); 74.39 (d); 74.49 (d);
111.59 (d); 113.99 (s); 119.59 (d); 121.94 (s); 123.00 (d); 125.33 (d); 125.57 (s); 129.05 (s); 132.72 (s);
138.25 (s); 141.58 (s); 141.75 (s). EI-MS: 268 (10, [M+1 ]+), 267 (47, M+), 249 (75), 221 (100), 206
(32), 204 (37), 191 (15), 111 (11). HR-MS: 267.1262 (C17H17NOþ2 ; calc. 267.1260).
Data of 8d (trans). IR: 3314, 2918, 1685, 1609, 1559, 1518, 1457, 1381, 1340, 1296, 1250, 993, 731. 1H-
NMR (CD3OD): 2.43 (s, 3 H); 2.82 (m, 1 H); 2.86 (s, 3 H); 3.44 (dd, J=16.8, 5.4, 1 H); 4.40–4.42 (m, 1
H); 5.16 (d, 1 H); 7.09–7.14 (m, 1 H); 7.27–7.32 (m, 1 H); 7.44–7.46 (m, 1 H); 8.09–8.12 (m, 1 H). 13C-
NMR (CD3OD): 13.50 (q); 16.72 (q); 38.73 (t); 80.24 (d); 81.84 (d); 111.58 (d); 114.17 (s); 119.54 (d);
122.20 (s); 123.00 (d); 125.25 (d); 125.58 (s); 129.23 (s); 133.13 (s); 139.48 (s); 141.79 (s); 141.87 (s).
EI-MS: 268 (12, [M+1]+), 267 (55, M+), 249 (77), 235 (19), 234 (21), 221 (100), 218 (14), 217 (11), 206
(31), 204 (35), 194 (11), 191 (13), 165 (11), 111 (10). HR-MS: 267.1259 (M+, C17H17NO2þ ; calc. 267.1260).
Ellipticine (=5,11-Dimethyl-6H-pyrido[4,3-b]carbazole; 1a). To a stirred soln. of a (nonseparated)
mixture of 8c/8d (0.10 g, 0.37 mmol) and aq. phosphate buffer (pH 8; 2 ml) in t-BuOH (6 ml), NaIO4
(0.16 g, 7.5 mmol) was added. After 6 h, NH4OAc (0.29 g, 3.6 mmol) was added, and stirring was contin-
3
)
Signal splitting due to atropisomerism.